Basal Cell Carcinoma: Diagnosis, Treatment and Prognosis
A special issue of Current Oncology (ISSN 1718-7729). This special issue belongs to the section "Dermato-Oncology".
Deadline for manuscript submissions: 31 January 2026 | Viewed by 34
Special Issue Editor
Special Issue Information
Dear Colleagues,
Basal cell carcinoma (BCC) is the most common type of skin cancer, affecting millions worldwide. It originates in the basal cells of the epidermis and presents with many faces, among other features: shiny bumps, often with ulcerations, whitish plates resembling scars, and scaly patches growing on areas such as the face, scalp, trunk, and arms. While BCC grows slowly and rarely metastasizes, its early detection and appropriate treatment are crucial to preventing local tissue damage and recurrence.
This Special Issue aims to explore the latest advancements in BCC diagnosis, treatment, and prevention. Topics of interest include innovative diagnostic techniques, surgical and non-surgical treatment modalities, targeted therapies, and strategies for long-term management and prevention. We welcome both original research articles and review papers that provide insights into improving patient outcomes and addressing challenges in BCC care.
Dr. Andrzej Bieniek
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Current Oncology is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- basal cell carcinoma
- skin cancer
- diagnostic techniques
- surgical and non-surgical treatment modalities
- targeted therapies
- long-term management and prevention
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
